{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:15:03Z","timestamp":1788491703537,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs, LLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40744-021-00420-x","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T15:02:46Z","timestamp":1642258966000},"page":"285-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Usage of C-Reactive Protein Testing in the Diagnosis and Monitoring of Psoriatic Arthritis (PsA): Results from a Real-World Survey in the USA and Europe"],"prefix":"10.1007","volume":"9","author":[{"given":"A.","family":"Ogdie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Tillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5626-3163","authenticated-orcid":false,"given":"N.","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. D.","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. C.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"issue":"6","key":"420_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jdv.12257","volume":"28","author":"S Beygi","year":"2014","unstructured":"Beygi S, Lajevardi V, Abedini R. C-reactive protein in psoriasis: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28(6):700\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"420_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3899\/jrheum.180195","volume":"46","author":"M Elmamoun","year":"2019","unstructured":"Elmamoun M, Leung YY, O\u2019Sullivan D, Steinkoenig I, Chandran V, Gladman DD, et al. Using acute-phase reactants to inform the development of instruments for the updated psoriatic arthritis core outcome measurement set. J Rheumatol. 2019;46(3):266\u201373.","journal-title":"J Rheumatol"},{"issue":"Suppl 10","key":"420_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/acr.24242","volume":"72","author":"A Ogdie","year":"2020","unstructured":"Ogdie A, Coates LC, Mease P. Measuring outcomes in psoriatic arthritis. Arthritis Care Res (Hoboken). 2020;72(Suppl 10):82\u2013109.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"420_CR4","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, Karavali M, Piercy J. Real-world physician and patient behaviour across countries: disease-specific programmes\u2014a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"key":"420_CR5","unstructured":"European Pharmaceutical Market Research Association (EphMRA). Code of Conduct. 2019. https:\/\/www.ephmra.org\/standards\/code-of-conduct\/. Accessed Sep 2019."},{"key":"420_CR6","unstructured":"US Department of Health and Human Services. Summary of the HIPAA Privacy Rule 2003. 2003. http:\/\/www.hhs.gov\/sites\/default\/files\/privacysummary.pdf. Accessed Sep 2019."},{"key":"420_CR7","unstructured":"Health Information Technology (HITECH). Health Information Technology Act 2009. 2009. https:\/\/www.healthit.gov\/sites\/default\/files\/hitech_act_excerpt_from_arra_with_index.pdf. Accessed Sep 2019."},{"issue":"1","key":"420_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.semarthrit.2020.11.005","volume":"51","author":"JE Pope","year":"2020","unstructured":"Pope JE, Choy EH. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum. 2020;51(1):219\u201329.","journal-title":"Semin Arthritis Rheum"},{"issue":"22","key":"420_CR9","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","volume":"282","author":"M Visser","year":"1999","unstructured":"Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131\u20135.","journal-title":"JAMA"},{"key":"420_CR10","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1038\/nutd.2012.26","volume":"2","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ. The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes. 2012;2:e54.","journal-title":"Nutr Diabetes"},{"issue":"3","key":"420_CR11","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/bjd.18227","volume":"182","author":"A Green","year":"2020","unstructured":"Green A, Shaddick G, Charlton R, Snowball J, Nightingale A, Smith C, et al. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis. Br J Dermatol. 2020;182(3):714\u201320.","journal-title":"Br J Dermatol"},{"issue":"7","key":"420_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/1346-8138.13213","volume":"43","author":"A Asahina","year":"2016","unstructured":"Asahina A, Umezawa Y, Yanaba K, Nakagawa H. Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: long-term differential effects of biologics. J Dermatol. 2016;43(7):779\u201384.","journal-title":"J Dermatol"},{"issue":"3","key":"420_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.23298","volume":"70","author":"D Cretu","year":"2018","unstructured":"Cretu D, Gao L, Liang K, Soosaipillai A, Diamandis EP, Chandran V. Differentiating Psoriatic Arthritis From Psoriasis Without Psoriatic Arthritis Using Novel Serum Biomarkers. Arthritis Care Res (Hoboken). 2018;70(3):454\u201361.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"420_CR14","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3899\/jrheum.180971","volume":"46","author":"D van der Heijde","year":"2019","unstructured":"van der Heijde D, Gladman DD, FitzGerald O, Kavanaugh A, Graham D, Wang C, et al. Radiographic progression according to baseline C-reactive protein levels and other risk factors in psoriatic arthritis treated with tofacitinib or adalimumab. J Rheumatol. 2019;46(9):1089\u201396.","journal-title":"J Rheumatol"},{"issue":"3","key":"420_CR15","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/ar3049","volume":"12","author":"DD Gladman","year":"2010","unstructured":"Gladman DD, Mease PJ, Choy EH, Ritchlin CT, Perdok RJ, Sasso EH. Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT. Arthritis Res Ther. 2010;12(3):R113.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"420_CR16","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s10067-020-05065-9","volume":"39","author":"M Haroon","year":"2020","unstructured":"Haroon M, Gallaghar P, Ahmad M, FitzGerald O. Elevated CRP even at the first visit to a rheumatologist is associated with long-term poor outcomes in patients with psoriatic arthritis. Clin Rheumatol. 2020;39(10):2951\u201361.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"420_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jaad.2015.02.004","volume":"72","author":"JJ Wu","year":"2015","unstructured":"Wu JJ, Rowan CG, Bebchuk JD, Anthony MS. Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis. J Am Acad Dermatol. 2015;72(5):917\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"420_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/M15-0288","volume":"163","author":"WP Battisti","year":"2015","unstructured":"Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med. 2015;163(6):461\u20134.","journal-title":"Ann Intern Med"},{"key":"420_CR19","unstructured":"International Committee of Medical Journal Editors (ICMJE). Defining the role of authors and contributors. 2020. http:\/\/www.icmje.org\/recommendations\/browse\/roles-and-responsibilities\/defining-the-role-of-authors-and-contributors.html. Accessed Jan 2020."}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-021-00420-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00420-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T12:50:44Z","timestamp":1643892644000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-021-00420-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00420-x","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}